文献速递小儿眼科与斜弱视白内障与屈光手术青光眼

婴儿无晶状体眼治疗研究中5岁时眼球轴长增长情况

Globe Axial Length Growth at Age 5 Years in the Infant Aphakia Treatment Study.
PubMed 文献 · Ophthalmology · 2017-02-10

该研究比较单眼白内障患儿在1至7月龄接受手术至5岁时术眼与对侧未手术眼的轴长增长。术眼与对侧眼轴长在术前和最终随访时均有显著差异,但轴长增长量无显著差异,且接触镜与人工晶状体两组间轴长变化相似,与视力结局无关,而接受额外手术清除视轴混浊或诊断为青光眼的眼轴长增长更多。

要点

  • 术眼与对侧眼轴长增长量无显著差异(3.3 vs 3.5 mm,P=0.31)。
  • 接触镜与人工晶状体两组轴长变化相似(3.2 vs 3.4 mm,P=0.53)。
  • 接受额外手术清除视轴混浊的眼轴长增长显著更多(3.8 vs 2.7 mm,P=0.013)。

核心结论

  • 婴儿期单眼白内障术后眼轴增长与对侧未手术眼相似,尽管手术时轴长较短。
  • 接触镜与人工晶状体两组轴长变化相似,与视力结局无关,接受额外手术清除视轴或诊断为青光眼的眼轴长增长更高。

研究设计与样本

  • 比较性病例系列,纳入婴儿无晶状体眼治疗研究(IATS)的患儿。
  • 分析基线及5岁时轴长,比较术眼与对侧眼、视力结局及治疗方式(接触镜 vs 人工晶状体)。
  • 青光眼或可疑青光眼眼排除于主要分析,另行报告。

主要发现

  • 术前术眼与对侧眼轴长分别为18.1 vs 18.7 mm(P<0.0001),最终随访时为21.4 vs 22.1 mm(P=0.0004)。
  • 术眼与对侧眼轴长增长量分别为3.3 vs 3.5 mm(P=0.31),无显著差异。
  • 接触镜组与人工晶状体组轴长变化分别为3.2 mm和3.4 mm(P=0.53),与视力结局无关(P=0.85)。
  • 接受额外手术清除视轴混浊的眼轴长增长3.8 mm,未接受者为2.7 mm(P=0.013)。
  • 青光眼眼轴长增长5.7 mm,无青光眼者为3.3 mm,可疑青光眼者为4.3 mm。

关键数值与推荐

  • 主要结局为术前至5岁时的轴长增长。
  • 64例患者有基线双眼轴长数据,69例患者有5岁时双眼轴长数据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report the longitudinal change in axial length (AL) from the time of unilateral cataract surgery at age 1 to 7 months to age 5 years, and to compare AL growth of operated eyes with that of fellow unoperated eyes. DESIGN: Comparative case series. PARTICIPANTS: Infants enrolled in the Infant Aphakia Treatment Study (IATS). METHODS: The AL at baseline and age 5 years and change in AL were analyzed relative to treated versus fellow eye, visual outcome, and treatment modality (contact lens [CL] vs. intraocular lens [IOL]). Eyes with glaucoma or glaucoma suspect were excluded from primary analysis but reported separately. MAIN OUTCOME MEASURES: The AL growth from preoperative to age 5 years. RESULTS: Seventy patients were eligible; however, AL data for both eyes were available for 64 patients at baseline and 69 patients at age 5 years. The AL was significantly different between treated and fellow eyes preoperatively (18.1 vs. 18.7 mm, P < 0.0001) and at the final follow-up (21.4 vs. 22.1 mm, P = 0.0004). The difference in AL growth between treated and fellow eyes was not significant (3.3 vs. 3.5 mm, P = 0.31). The change in AL in eyes was similar with both treatments (CL 3.2 mm and IOL 3.4 mm, P = 0.53) and did not correlate with visual outcomes (P = 0.85). Eyes receiving additional surgery to clear the visual axis opacification grew significantly more compared with eyes not receiving surgery to clear the visual axis (3.8 vs. 2.7 mm, P = 0.013). Patients with glaucoma showed significantly more eye growth (5.7 mm) than those without glaucoma (3.3 mm) and glaucoma suspects (4.3 mm). CONCLUSIONS: Eyes treated for monocular cataract in infancy have axial growth similar to that of fellow eyes, despite having a shorter AL at the time of surgery. The change in AL in eyes was similar with both treatments (CL and IOL), did not correlate with visual outcomes, and was higher in eyes receiving additional surgery to clear the visual axis or eyes diagnosed with glaucoma.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Wilson ME, Trivedi RH, Weakley DR, et al. Globe Axial Length Growth at Age 5 Years in the Infant Aphakia Treatment Study. Ophthalmology. 2017. PMID: 28196730. doi:10.1016/j.ophtha.2017.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。